GlassScriptPhysician profile
Lynette A Medlen
NPI 1740685668
$3,263.46
in general payments reported to CMS, 2019-2025
35 companies · $1,232 in 2025
The $1,232 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $452 · 2023: $566 · 2024: $1,013 · 2025: $1,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,811.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $296.38 | 2023-2024 | Axonics, Bulkamid |
| Pfizer INC. | $273.97 | 2022-2025 | |
| Urogen Pharma, INC. | $228.24 | 2022-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $226.87 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $174.65 | 2022-2025 | |
| Boston Scientific Corporation | $170.75 | 2023-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Moses |
| Myriad Genetic Laboratories, INC. | $165.81 | 2022-2024 | Prolaris |
| Abbvie INC. | $157.88 | 2023-2025 | |
| Teleflex LLC | $133.27 | 2025 | Barrigel |
| Astellas Pharma US INC | $123.15 | 2022-2025 | Xtandi, Veozah, Myrbetriq |
| Alexion Pharmaceuticals, INC. | $121.87 | 2022 | |
| Dendreon Pharmaceuticals LLC | $120.56 | 2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $110.27 | 2023 | Pylarify |
| Photocure INC | $91.33 | 2024-2025 | Cysview |
| C. R. Bard, INC. & Subsidiaries | $85.58 | 2025 | Purewick Female External Catheter, Bard Urinary Drainage Bag |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $81.32 | 2025 | |
| Endo USA, INC. | $81.01 | 2024-2025 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $65.60 | 2023-2024 | |
| Janssen Biotech, INC. | $59.58 | 2022-2025 | Erleada |
| Baxter Healthcare | $53.87 | 2023-2024 | Perclot |
| Tempus Ai, INC | $46.98 | 2024 | Xt Cdx |
| Olympus America INC. | $46.39 | 2025 | Oes Cystonephrofiberscope, Olympus, Bovie |
| Tolmar Pharmaceuticals, INC. | $40.98 | 2022 | |
| Merck Sharp & Dohme LLC | $37.71 | 2022-2024 | Keytruda |
| Tolmar, INC. | $36.00 | 2023-2024 | |
| Inspire Medical Systems, INC. | $34.39 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $31.41 | 2024 | |
| Novartis Pharmaceuticals Corporation | $30.59 | 2025 | |
| Coloplast Corp | $30.40 | 2025 | |
| Laborie Medical Technologies Corp. | $20.41 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Accord Healthcare, INC. | $19.26 | 2024 | |
| Verity Pharmaceuticals INC. | $18.99 | 2025 | Tlando |
| Ethicon US, LLC | $17.94 | 2025 | Echelon Endopath, Ligaclip |
| Azurity Pharmaceuticals, INC. | $16.33 | 2025 | Azmiro |
| E.R. Squibb & Sons, L.L.C. | $13.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynette Medlen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.